IDEXX Laboratories, Inc. (IDXX)
608.41
-10.51
(-1.70%)
USD |
NASDAQ |
Mar 06, 16:00
609.09
+0.68
(+0.11%)
After-Hours: 20:00
IDEXX Laboratories Cash from Investing (Quarterly) : -28.13M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -2.802B |
| Intuitive Surgical, Inc. | -209.40M |
| Merck & Co., Inc. | -11.20B |
| Pfizer Inc. | -6.146B |
| Revvity, Inc. | -20.45M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 352.02M |
| Cash from Financing (Quarterly) | -351.96M |
| Free Cash Flow | 1.040B |
| Free Cash Flow Per Share (Quarterly) | 4.006 |
| Free Cash Flow to Equity (Quarterly) | 459.29M |
| Free Cash Flow to Firm (Quarterly) | 330.89M |
| Free Cash Flow Yield | 2.11% |